| Original language | English |
|---|---|
| Pages (from-to) | S1281-S1284 |
| Journal | Translational Cancer Research |
| Volume | 6 |
| Issue number | S7 |
| Publication status | Published - 2017 |
Cite this
Mazzotta, M., Barba, M., Pizzuti, L., & Vici, P. (2017). Is there a role for adjuvant pertuzumab in HER2-positive breast cancer? Translational Cancer Research, 6(S7), S1281-S1284.
Is there a role for adjuvant pertuzumab in HER2-positive breast cancer? / Mazzotta, M.; Barba, M.; Pizzuti, L.; Vici, P.
In: Translational Cancer Research, Vol. 6, No. S7, 2017, p. S1281-S1284.Research output: Contribution to journal › Article
Mazzotta, M, Barba, M, Pizzuti, L & Vici, P 2017, 'Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?', Translational Cancer Research, vol. 6, no. S7, pp. S1281-S1284.
Mazzotta M, Barba M, Pizzuti L, Vici P. Is there a role for adjuvant pertuzumab in HER2-positive breast cancer? Translational Cancer Research. 2017;6(S7):S1281-S1284.
@article{3af08ed722cf41c0818ba4a5c77a47c2,
title = "Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?",
author = "M. Mazzotta and M. Barba and L. Pizzuti and P. Vici",
year = "2017",
language = "English",
volume = "6",
pages = "S1281--S1284",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",
number = "S7",
}
TY - JOUR
T1 - Is there a role for adjuvant pertuzumab in HER2-positive breast cancer?
AU - Mazzotta, M.
AU - Barba, M.
AU - Pizzuti, L.
AU - Vici, P.
PY - 2017
Y1 - 2017
M3 - Article
VL - 6
SP - S1281-S1284
JO - Translational Cancer Research
JF - Translational Cancer Research
SN - 2218-676X
IS - S7
ER -